Home > Boards > US OTC > Cannabis > Cannabics Pharmaceuticals Inc. (CNBX)

From the full analyst report: $7 Target PPS!!! “The

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
bybtrader Member Profile
 
Followed By 24
Posts 1,364
Boards Moderated 0
Alias Born 09/29/16
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/19/2021 2:52:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 9:06:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 3:48:03 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/14/2021 3:51:56 PM
Cannabics names Inbar Maymon-Pomeranchik as independent board director Seeking Alpha - 7/7/2021 9:03:31 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 12:24:17 PM
Cannabics gets European Patent for personalized medicine drug discovery technology Seeking Alpha - 5/25/2021 8:55:11 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/18/2021 6:07:46 AM
Cannabics files a PCT patent application for proprietary cancer treatment formulations Seeking Alpha - 5/11/2021 8:59:21 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 5/10/2021 10:41:25 AM
Cannabics gets "notice of allowance" from the Mexican Patent and Trademark Office Seeking Alpha - 5/6/2021 9:35:34 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/28/2021 7:47:41 AM
Cannabics launches research program in melanoma treatment development push Seeking Alpha - 4/26/2021 9:35:46 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/14/2021 12:43:14 PM
Cannabics' RCC-33 prolongs survival rate in mice inoculated with human colorectal cancer cells Seeking Alpha - 3/17/2021 9:38:20 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 3/12/2021 6:05:32 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 2/23/2021 3:28:30 PM
Cannabics Pharmaceuticals posts final results from RCC-33 mice cancer study Seeking Alpha - 2/16/2021 9:35:05 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 1/14/2021 4:03:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/21/2020 8:55:59 AM
bybtrader   Wednesday, 01/10/18 04:16:25 PM
Re: Midnightmatt post# 2909
Post # of 5283 
From the full analyst report: $7 Target PPS!!!

“The company’s stock has unsurprisingly found enormous strength in the recent past. It has been powering due to the favorable impact of the company’s recent announcements and growing popularity of the industry. Consequently, analysts tracking the stock has increased their price target for CNBX shares to $7/equity share, representing 350 percent upside potential.”


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences